comparemela.com

Latest Breaking News On - Treatment selection - Page 1 : comparemela.com

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJohn sonnenbergCherise chin fattAdam savitzSamanthav goncalvesNicholasj cooperPeter emmelAdamj savitzGuhan sundarMichael avissarDaniel mathalonGriffin hallBarbara echevarriaMark oplerFaizan badami

Selecting Between Adalimumab Biosimilars for Your Patients

Providers in rheumatology, dermatology and gastrointestinal disease talk about how they are selecting between the various adalimumab biosimilars available for their patients.

Kostas botsoglouSophia humphreysJamiet broganJordan axelradPeter lioTreatment selection

Selecting CD Treatment in Special Scenarios

Experts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.

Remo panaccioneSara horstMiguel regueiroDavid rubinMarla dubinskyCrohn x27s diseaseTreatment selectionExtra intestinal manifestations

Expert Perspectives on Emerging Data Surrounding BTK Inhibitor Resistance in CLL

Faculty offer expert insights into emerging data on BTK inhibitor resistance in CLL, referencing earlier findings that indicate the potential existence of mutations before BTK inhibitor exposure and the process of clonal selection.

Chaitras ujjaniRichard furmanNews networkChronic lymphocytic leukemiaContinuous btki therapyFixed duration therapyTumor lysis monitoringElevate tnMash 2023Elevate rrTreatment naïve cllNewly diagnosed cllRelapsed cllRefractory cllReal world dataTreatment resistance

Treatment Strategies for Managing BTK Inhibitor Intolerance in CLL

Richard Furman, MD, outlines his strategy for addressing BTK inhibitor intolerance in CLL patients, underscoring the significance of BTK inhibitors in CLL treatment and advocating for transitioning to an alternative BTK inhibitor rather than completely discontinuing the class in cases of drug intolerance.

Chaitras ujjaniRichard furmanNews networkChronic lymphocytic leukemiaContinuous btki therapyFixed duration therapyTumor lysis monitoringElevate tnMash 2023Elevate rrTreatment naïve cllNewly diagnosed cllRelapsed cllRefractory cllReal world dataTreatment resistance

vimarsana © 2020. All Rights Reserved.